199 related articles for article (PubMed ID: 38698538)
21. Precision oncology in the age of integrative genomics.
Kumar-Sinha C; Chinnaiyan AM
Nat Biotechnol; 2018 Jan; 36(1):46-60. PubMed ID: 29319699
[TBL] [Abstract][Full Text] [Related]
22. [Precision oncology and molecular tumor boards].
Mack E; Horak P; Fröhling S; Neubauer A
Inn Med (Heidelb); 2024 May; 65(5):462-471. PubMed ID: 38652307
[TBL] [Abstract][Full Text] [Related]
23. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
Blumenthal GM; Mansfield E; Pazdur R
JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
[No Abstract] [Full Text] [Related]
24. From Tissue-Agnostic to N-of-One Therapies: (R)Evolution of the Precision Paradigm.
Adashek JJ; Subbiah V; Kurzrock R
Trends Cancer; 2021 Jan; 7(1):15-28. PubMed ID: 33008795
[TBL] [Abstract][Full Text] [Related]
25. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
[TBL] [Abstract][Full Text] [Related]
26. Personalised medicine in veterinary oncology: one to cure just one.
Klopfleisch R
Vet J; 2015 Aug; 205(2):128-35. PubMed ID: 25641551
[TBL] [Abstract][Full Text] [Related]
27. Future Clinical Trials: Genetically Driven Trials.
Astsaturov I
Surg Oncol Clin N Am; 2017 Oct; 26(4):791-797. PubMed ID: 28923231
[TBL] [Abstract][Full Text] [Related]
28. Clinical interpretation of whole-genome and whole-transcriptome sequencing for precision oncology.
Jobanputra V; Wrzeszczynski KO; Buttner R; Caldas C; Cuppen E; Grimmond S; Haferlach T; Mullighan C; Schuh A; Elemento O
Semin Cancer Biol; 2022 Sep; 84():23-31. PubMed ID: 34256129
[TBL] [Abstract][Full Text] [Related]
29. Molecular testing in oncology: problems, pitfalls and progress.
O'Brien CP; Taylor SE; O'Leary JJ; Finn SP
Lung Cancer; 2014 Mar; 83(3):309-15. PubMed ID: 24472389
[TBL] [Abstract][Full Text] [Related]
30. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
31. Implementing precision cancer medicine in the genomic era.
Chen HZ; Bonneville R; Roychowdhury S
Semin Cancer Biol; 2019 Apr; 55():16-27. PubMed ID: 29857039
[TBL] [Abstract][Full Text] [Related]
32. Reasons to be testing: the dawn of complex molecular profiling in routine oncology practice.
Beer PA; Cooke SL; Chang DK; Biankin AV
Ann Oncol; 2019 Nov; 30(11):1691-1694. PubMed ID: 31665210
[No Abstract] [Full Text] [Related]
33. Pharmacogenomic biomarkers for personalized cancer treatment.
Rodríguez-Antona C; Taron M
J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
[TBL] [Abstract][Full Text] [Related]
34. [From panel diagnostics to comprehensive genomic analysis : Infobesity or empowerment?].
Leichsenring J; Kazdal D; Ploeger C; Allgäuer M; Endris V; Volckmar AL; Neumann O; Kirchner M; Penzel R; Rempel E; Budczies J; Schirmacher P; Fröhling S; Stenzinger A
Pathologe; 2019 May; 40(3):235-242. PubMed ID: 31089797
[TBL] [Abstract][Full Text] [Related]
35. Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways.
Doherty M; Metcalfe T; Guardino E; Peters E; Ramage L
Ann Oncol; 2016 Aug; 27(8):1644-6. PubMed ID: 27117532
[No Abstract] [Full Text] [Related]
36. Understanding inequities in precision oncology diagnostics.
Dutta R; Vallurupalli M; McVeigh Q; Huang FW; Rebbeck TR
Nat Cancer; 2023 Jun; 4(6):787-794. PubMed ID: 37248397
[TBL] [Abstract][Full Text] [Related]
37. Network science in clinical trials: A patient-centered approach.
Manem VSK; Salgado R; Aftimos P; Sotiriou C; Haibe-Kains B
Semin Cancer Biol; 2018 Oct; 52(Pt 2):135-150. PubMed ID: 29278737
[TBL] [Abstract][Full Text] [Related]
38. Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.
Schmidt KT; Chau CH; Price DK; Figg WD
J Clin Pharmacol; 2016 Dec; 56(12):1484-1499. PubMed ID: 27197880
[TBL] [Abstract][Full Text] [Related]
39. [Personalized medicine in oncology].
Lörsch AM; Jung J; Lange S; Pfarr N; Mogler C; Illert AL
Pathologie (Heidelb); 2024 May; 45(3):180-189. PubMed ID: 38568256
[TBL] [Abstract][Full Text] [Related]
40. Practical aspects of NGS-based pathways analysis for personalized cancer science and medicine.
Kotelnikova EA; Pyatnitskiy M; Paleeva A; Kremenetskaya O; Vinogradov D
Oncotarget; 2016 Aug; 7(32):52493-52516. PubMed ID: 27191992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]